K2M IPO Could be the Backbone of the Spine Surgery Market

K2M CEO Eric Major explains how the company is focused on designing, developing and commercializing proprietary complex spine technologies to serve the global $10 billion spine surgery market.

Author:: Jill Malandrino
Publish date:: May 9, 2014 9:18 AM EDT

K2M (KTWO) commenced trading on the NASDAQ May 8, 2014. CEO Eric Major explains the company is focused on designing, developing and commercializing innovative and proprietary complex spine technologies and techniques to serve the global $10 billion spine surgery market. Major explains that K2M is one of the fastest growing companies in spine and expects that trajectory to continue, with robust products in the pipeline and multiple products to be introduced over the next 12 months.